Skip to content
Company Analysis

Globus Medical, Inc. GMED

A comprehensive view of key metrics, scores, and financial health for Globus Medical, Inc.

Overview of Globus Medical, Inc.

GMED NYQ
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Large Cap
Globus Medical, Inc. (GMED), is a Large Cap company, in the Medical Devices industry, last closed at $80.39, about 53.2% overvalued vs fair value, +36.5% 1Y return, placing in the top 25% of its sector.
Metrics Rev Growth 16.7% ROE 12.3% Gross Margin 67.4%
USD 80.39
-0.16%
(Delayed)
• Vol 90d: 34.1%
52-Week Range
Market Cap
$10.98B
Enterprise Value
$10.57B
Overall Score
View breakdown
Overall
Growth
Good
Profitability
Excellent
Health
Fair
Efficiency
Fair
Valuation
Fair
Growth
Good
Profitability
Excellent
Health
Fair
Efficiency
Fair
Valuation
Fair
Completeness: 82%
Confidence: 90%
Updated: Mar 8
Top Beats

Quick Facts

Website https://www.globusmedical.com
HQ Audubon, PA
Employees 6,000
Fiscal year Dec 31

Next Events

Earnings Aug 6 Estimated

Fair Value Snapshot

Bear Base Bull
$34
$38
$42
Current: $80.39 -53% vs base

Engine Room Money Flow™

Large Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$2.9B
16.7%%
Gross Profit
$2.0B
33.5%%
Operating Income (GAAP)
$479.8M
118.4%%
EBITDA
$729.9M
54.1%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
67.4%
Excellent

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$85.8M
21.2% of Free Cash Flow

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
1/2
Improving
0
High Impact
1
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Globus Medical, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
72
/100
Moderate
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Moderate
58
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 97% Coverage
Trade-Off Triangle Visualization A ternary plot showing GMED's balance between Growth (28.6%), Profitability (42.2%), and Safety (29.2%). Growth 29% Safety 29% Profitability 42%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

54th percentile vs peers
55
Key Signals
Rev Growth YoY 16.7% 70p Revenue CAGR 3Y 42.2% 88p EPS Growth YoY -30.3% 21p EPS CAGR 3Y -19.7% 21p Asset Growth YoY 1.0% 56p
Strengths
  • Revenue CAGR 3Y in top 20% of peers (42.2%, 88th percentile)
  • FCF Margin in top 20% of peers (20.0%, 92th percentile)
  • Operating Margin in top 20% of peers (16.3%, 85th percentile)
  • Interest Coverage (EBITDA) in top 20% of peers (17.22, 83th percentile)
Risks

No significant risks identified for this axis.

Profitability

80th percentile vs peers
81
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

55th percentile vs peers
56
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Globus Medical, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$37.63
- - -
-53.2% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000